
Taurine (500mg) + Acetylcysteine (150mg)
Active composition
+1 more active ingredient
Acetylcysteine breaks disulfide bonds in mucus, reducing its viscosity and promoting mucus clearance.
Medical applications
Kdfit Tablet is a pharmaceutical formulation containing Taurine 500 mg and Acetylcysteine 150 mg, designed to support cellular health and enhance antioxidant defenses. Taurine, a sulfur-containing amino acid, plays a critical role in cardiovascular function, osmoregulation, and modulation of calcium signaling, contributing to overall cellular stability and metabolic regulation. Acetylcysteine, a precursor to glutathione, acts as a potent antioxidant and mucolytic agent, facilitating the reduction of oxidative stress and promoting detoxification processes. The combination of Taurine and Acetylcysteine in Kdfit Tablet offers synergistic benefits, particularly in conditions characterized by oxidative damage, inflammation, and impaired cellular function. This formulation may be beneficial in supporting liver health, respiratory conditions with mucus hypersecretion, and metabolic disorders requiring enhanced antioxidant support. Kdfit Tablet is intended for use under medical supervision, with dosage and duration tailored to individual patient needs. It is contraindicated in individuals with known hypersensitivity to either component. Adverse effects are generally mild and infrequent but may include gastrointestinal discomfort or allergic reactions. Kdfit Tablet should be stored in a cool, dry place, away from direct sunlight, and kept out of reach of children. Consultation with a healthcare professional is recommended before initiating therapy to ensure safety and efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Kdfit Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Kdfit Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Kdfit Tablet is safe to use in patients with kidney disease. No dose adjustment of Kdfit Tablet is recommended.
Exercise Caution
It is not known whether Kdfit Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Kdfit Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Kdfit Tablet

Taurine (500mg) + Acetylcysteine (150mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Acetylcysteine breaks disulfide bonds in mucus, reducing its viscosity and promoting mucus clearance.
Medical applications
Kdfit Tablet is a pharmaceutical formulation containing Taurine 500 mg and Acetylcysteine 150 mg, designed to support cellular health and enhance antioxidant defenses. Taurine, a sulfur-containing amino acid, plays a critical role in cardiovascular function, osmoregulation, and modulation of calcium signaling, contributing to overall cellular stability and metabolic regulation. Acetylcysteine, a precursor to glutathione, acts as a potent antioxidant and mucolytic agent, facilitating the reduction of oxidative stress and promoting detoxification processes. The combination of Taurine and Acetylcysteine in Kdfit Tablet offers synergistic benefits, particularly in conditions characterized by oxidative damage, inflammation, and impaired cellular function. This formulation may be beneficial in supporting liver health, respiratory conditions with mucus hypersecretion, and metabolic disorders requiring enhanced antioxidant support. Kdfit Tablet is intended for use under medical supervision, with dosage and duration tailored to individual patient needs. It is contraindicated in individuals with known hypersensitivity to either component. Adverse effects are generally mild and infrequent but may include gastrointestinal discomfort or allergic reactions. Kdfit Tablet should be stored in a cool, dry place, away from direct sunlight, and kept out of reach of children. Consultation with a healthcare professional is recommended before initiating therapy to ensure safety and efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Kdfit Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Kdfit Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Kdfit Tablet is safe to use in patients with kidney disease. No dose adjustment of Kdfit Tablet is recommended.
Exercise Caution
It is not known whether Kdfit Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Kdfit Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Kdfit Tablet















